Advertisement GenVec obtains grant for PEDF program - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

GenVec obtains grant for PEDF program

GenVec has received a grant from the National Eye Institute, of the National Institutes of Health, to explore mechanisms regulating pigment epithelium-derived factor, a key regulator of blood vessel growth in the eye.

This grant valued at approximately $546,000 over two years, will support research being conducted at GenVec.

Rick King, senior vice president of research at GenVec, said: “A key objective of this grant is to expand our understanding of how pigment epithelium-derived factor (PEDF) influences blood vessel growth in the eye. We believe that research conducted under this grant may lead to the discovery and testing of improved strategies to treat neovascular diseases of the eye.”